Company: GEHC
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001932393-25-000005
Chunk: 152

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 8
Chunk 152
---
For the years ended December 31(In millions, except per share amounts)202420232022Numerator:Net income from continuing operations$2,050 $1,618 $1,949 Net (income) loss attributable to noncontrolling interests(57)(46)(51)Net income from continuing operations attributable to GE HealthCare1,993 1,572 1,898 Deemed preferred stock dividend of redeemable noncontrolling interest— (183)— Net income from continuing operations attributable to GE HealthCare common stockholders1,993 1,389 1,898 Income (loss) from discontinued operations, net of taxes— (4)18 Net income attributable to GE HealthCare common stockholders$1,993 $1,385 $1,916 Denominator:Basic weighted-average shares outstanding456 455 454 Dilutive effect of common stock equivalents2 3 — Diluted weighted-average shares outstanding459 458 454 Basic Earnings Per Share:Continuing operations$4.37 $3.06 $4.18 Discontinued operations— (0.01)0.04 Attributable to GE HealthCare common stockholders4.37 3.05 4.22 Diluted Earnings Per Share:Continuing operations$4.34 $3.04 $4.18 Discontinued operations— (0.01)0.04 Attributable to GE HealthCare common stockholders4.34 3.03 4.22 Antidilutive securities(1)3 4 — (1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.

NOTE 18. SUPPLEMENTAL FINANCIAL INFORMATION

CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.As ofDecember 31, 2024December 31, 2023Cash and cash equivalents$2,874 $2,494 Short-term restricted cash16 10 Total Cash, cash equivalents, and restricted cash as presented in the Consolidated Statements of Financial Position2,889 2,504 Long-term restricted cash(1)3 2 Total Cash, cash equivalents, and restricted cash as presented in the Consolidated and Combined Statements of Cash Flows$2,893 $2,506 (1) Long